Janny Seto

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin

Marian Kruszynski, Bernard Lammek, Maurice Manning et al. · Journal of Medicinal Chemistry · 1980 · 448 citations

Neuropeptides, Altmetric Attention Score, Pharmacotherapy +20

Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin

Maurice Manning, Marian Kruszynski, Krzysztof Bańkowski et al. · Journal of Medicinal Chemistry · 1989 · 106 citations

Carboxy terminus of vasopressin required for activity but not binding

Maurice Manning, Aleksandra Olma, Wieslaw A. Kliś et al. · Nature · 1984 · 91 citations

Molecular Pharmacology, Biochemistry, Medicine +4

Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin

Maurice Manning, Aleksandra Olma, Wieslaw A. Kliś et al. · Journal of Medicinal Chemistry · 1982 · 76 citations

Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(.beta.-mercapto-.beta.,.beta.-pentamethylenepropionic acid), 2-D-isoleucine, 4-valine]arginine-vasopressin at position 4

Maurice Manning, E Nawrocka, Aleksandra Misicka et al. · Journal of Medicinal Chemistry · 1984 · 71 citations